Syndicated Research Studies

  The global companion animal medicine market was valued at USD 25.88 billion in 2025 and is projected to reach USD 66.96 billion by 2034, reflecting a CAGR of 11.22% from 2026 to 2034. Market expansion is supported by rapid progress in veterinary therapeutics, growing humanization of pets, rising pet-related spending, and evolving pet ownership trends worldwide. These factors continue to stimulate demand for advanced and specialized veterinary care. Continuous innovation in veterinary pharmaceuticals has enabled the development of more precise and effective treatments for various animal health conditions. Novel therapies are improving clinical outcomes, reducing side effects, and strengthening the demand for next-generation veterinary medicines. Increasing product approvals, a rising focus on precision medicine, expanding adoption of pet insurance, and surging animal health expenditure are further accelerating industry growth. The emergence of regenerative medicine and growing ...

Companion Animal Medicine Industry Overview The global  companion animal medicine market  size is anticipated to reach USD 32.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.6% from 2021 to 2028. The key factors driving the market for companion animal medicine include the rising pet population, the prevalence of diseases, and the availability of pet insurance. In Canada for example, 58% of households owned at least one dog or cat in 2020, according to the Canadian Animal Health Institute (CAHI). CAHI also reported a surge in feline vet visits following the start of the COVID-19 outbreak in 2020. Companion Animal Medicine Market Segmentation Grand View Research has segmented the global companion animal medicine market on the basis of animal type and region: Based on the Animal Type Insights, the market is segmented into Dogs, Cats, and Horses. The dogs segment dominated the market and accounted for...